Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009)

Kyung Hee Jung; Il Kyu Choi; Hee Seung Lee; Hong Hua Yan; Mi Kwon Son; Hyo Min Ahn; Jin Woo Hong; Chae Ok Yun; Soon Sun Hong

doi:10.1016/j.canlet.2017.06.019

Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009)

Kyung Hee Jung, Il Kyu Choi, Hee Seung Lee, Hong Hua Yan, Mi Kwon Son, Hyo Min Ahn, Jin Woo Hong, Chae Ok Yun, Soon Sun Hong

Department of New Biology

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Abstract

The authors regret that the grant number was mentioned incorrectly in the original article and the correct Grant number is “2015M3A9C4075818”. The authors would like to apologise for any inconvenience caused.

Original language	English
Pages (from-to)	93
Number of pages	1
Journal	Cancer Letters
Volume	404
DOIs	https://doi.org/10.1016/j.canlet.2017.06.019
State	Published - 28 Sep 2017

Bibliographical note

Publisher Copyright:
© 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.canlet.2017.06.019

Fingerprint

Dive into the research topics of 'Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009)'. Together they form a unique fingerprint.

Cite this

Jung, K. H., Choi, I. K., Lee, H. S., Yan, H. H., Son, M. K., Ahn, H. M., Hong, J. W., Yun, C. O., & Hong, S. S. (2017). Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009). Cancer Letters, 404, 93. https://doi.org/10.1016/j.canlet.2017.06.019

@article{6c490495174b468f8cd6e6e193ebf4d3,

title = "Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009)",

abstract = "The authors regret that the grant number was mentioned incorrectly in the original article and the correct Grant number is “2015M3A9C4075818”. The authors would like to apologise for any inconvenience caused.",

author = "Jung, {Kyung Hee} and Choi, {Il Kyu} and Lee, {Hee Seung} and Yan, {Hong Hua} and Son, {Mi Kwon} and Ahn, {Hyo Min} and Hong, {Jin Woo} and Yun, {Chae Ok} and Hong, {Soon Sun}",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2017",

month = sep,

day = "28",

doi = "10.1016/j.canlet.2017.06.019",

language = "English",

volume = "404",

pages = "93",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

}

Jung, KH, Choi, IK, Lee, HS, Yan, HH, Son, MK, Ahn, HM, Hong, JW, Yun, CO & Hong, SS 2017, 'Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009)', Cancer Letters, vol. 404, pp. 93. https://doi.org/10.1016/j.canlet.2017.06.019

Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009). / Jung, Kyung Hee; Choi, Il Kyu; Lee, Hee Seung et al.
In: Cancer Letters, Vol. 404, 28.09.2017, p. 93.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009)

AU - Jung, Kyung Hee

AU - Choi, Il Kyu

AU - Lee, Hee Seung

AU - Yan, Hong Hua

AU - Son, Mi Kwon

AU - Ahn, Hyo Min

AU - Hong, Jin Woo

AU - Yun, Chae Ok

AU - Hong, Soon Sun

PY - 2017/9/28

Y1 - 2017/9/28

N2 - The authors regret that the grant number was mentioned incorrectly in the original article and the correct Grant number is “2015M3A9C4075818”. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the grant number was mentioned incorrectly in the original article and the correct Grant number is “2015M3A9C4075818”. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85021057464&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2017.06.019

DO - 10.1016/j.canlet.2017.06.019

M3 - Comment/debate

C2 - 28646638

AN - SCOPUS:85021057464

SN - 0304-3835

VL - 404

SP - 93

JO - Cancer Letters

JF - Cancer Letters

ER -

Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166](S0304383517301738)(10.1016/j.canlet.2017.03.009)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this